Cargando…
Interaction between magnesium and methylglyoxal in diabetic polyneuropathy and neuronal models
OBJECTIVE: The lack of effective treatments against diabetic sensorimotor polyneuropathy demands the search for new strategies to combat or prevent the condition. Because reduced magnesium and increased methylglyoxal levels have been implicated in the development of both type 2 diabetes and neuropat...
Autores principales: | Strom, Alexander, Strassburger, Klaus, Schmuck, Martin, Shevalye, Hanna, Davidson, Eric, Zivehe, Fariba, Bönhof, Gidon, Reimer, Rudolph, Belgardt, Bengt-Frederik, Fleming, Thomas, Biermann, Barbara, Burkart, Volker, Müssig, Karsten, Szendroedi, Julia, Yorek, Mark A., Fritsche, Ellen, Nawroth, Peter P., Roden, Michael, Ziegler, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704399/ https://www.ncbi.nlm.nih.gov/pubmed/33166742 http://dx.doi.org/10.1016/j.molmet.2020.101114 |
Ejemplares similares
-
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy
por: Maalmi, Haifa, et al.
Publicado: (2022) -
Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes
por: Ziegler, Dan, et al.
Publicado: (2020) -
Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes
por: Maalmi, Haifa, et al.
Publicado: (2021) -
Lower serum extracellular superoxide dismutase levels are associated with polyneuropathy in recent-onset diabetes
por: Strom, Alexander, et al.
Publicado: (2017) -
BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy
por: Bönhof, Gidon J, et al.
Publicado: (2022)